GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Price-to-Tangible-Book

Vectus Biosystems (ASX:VBS) Price-to-Tangible-Book : 2.11 (As of Jul. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Price-to-Tangible-Book?

As of today (2024-07-27), Vectus Biosystems's share price is A$0.095. Vectus Biosystems's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.05. Hence, Vectus Biosystems's Price to Tangible Book Ratio of today is 2.11.

The historical rank and industry rank for Vectus Biosystems's Price-to-Tangible-Book or its related term are showing as below:

ASX:VBS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.64   Med: 8.26   Max: 280
Current: 1.9

During the past 8 years, Vectus Biosystems's highest Price to Tangible Book Ratio was 280.00. The lowest was 1.64. And the median was 8.26.

ASX:VBS's Price-to-Tangible-Book is ranked better than
64.6% of 1195 companies
in the Biotechnology industry
Industry Median: 2.74 vs ASX:VBS: 1.90

A closely related ratio is called PB Ratio. As of today, Vectus Biosystems's share price is A$0.095. Vectus Biosystems's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.05. Hence, Vectus Biosystems's P/B Ratio of today is 2.11.


Vectus Biosystems Price-to-Tangible-Book Historical Data

The historical data trend for Vectus Biosystems's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Price-to-Tangible-Book Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - - 6.67

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 8.02 6.67 6.67

Competitive Comparison of Vectus Biosystems's Price-to-Tangible-Book

For the Biotechnology subindustry, Vectus Biosystems's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Price-to-Tangible-Book falls into.



Vectus Biosystems Price-to-Tangible-Book Calculation

Vectus Biosystems's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.095/0.045
=2.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Vectus Biosystems Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems Headlines

No Headlines